Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Other-Long-Term-Liabilities" stands at 7.66 Billion United States Dollars as of 09/30/2025, the highest value since 06/30/2024.
As of the end of Merck & Company Inc's third quarter, the item "Other Long Term Liabilities" stands at 7.66 Billion USD. This represents an increase of 8.96 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 1.60 percent compared to the value the year prior.
The 1 year change in percent is 1.60.
The 3 year change in percent is -11.54.
The 5 year change in percent is -36.30.
The 10 year change in percent is -2.87.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Long Term Liabilities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Long Term Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Long Term Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Long Term Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Long Term Liabilities | 280,205,508,085.11 |